Flexible modelling of the dissolution performance of directly compressed tablets
Maclean, Natalie and Armstrong, John A. and Carroll, Mark A. and Salehian, Mohammad and Mann, James and Reynolds, Gavin and Johnston, Blair and Markl, Daniel (2024) Flexible modelling of the dissolution performance of directly compressed tablets. International Journal of Pharmaceutics, 656. 124084. ISSN 1873-3476 (https://doi.org/10.1016/j.ijpharm.2024.124084)
Preview |
Text.
Filename: Maclean-etal-IJP-2024-Flexible-modelling-of-the-dissolution-performance-of-directly-compressed-tablets.pdf
Final Published Version License: Download (1MB)| Preview |
Abstract
In this study, a compartmental disintegration and dissolution model is proposed for the prediction and evaluation of the dissolution performance of directly compressed tablets. This dissolution model uses three compartments (Bound, Disintegrated, and Dissolved) to describe the state of each particle of active pharmaceutical ingredient. The disintegration of the tablet is captured by three fitting parameters. Two disintegration parameters, β0 and βt,0 , describe the initial disintegration rate and the change in disintegration rate, respectively. A third parameter, α, describes the effect of the volume of dissolved drug on the disintegration process. As the tablet disintegrates, particles become available for dissolution. The dissolution rate is determined by the Nernst-Brunner equation, whilst taking into account the hydrodynamic effects within the vessel of a USP II (paddle) apparatus. This model uses the raw material properties of the active pharmaceutical ingredient (solubility, particle size distribution, true density), lending it towards early development activities during which time the amount of drug substance available may be limited. Additionally, the strong correlations between the fitting parameters and the tablet porosity indicate the potential to isolate the manufacturing effects and thus implement the model as part of a real-time release testing strategy for a continuous direct compression line.
ORCID iDs
Maclean, Natalie ORCID: https://orcid.org/0000-0003-0768-1673, Armstrong, John A. ORCID: https://orcid.org/0000-0003-1589-9365, Carroll, Mark A., Salehian, Mohammad ORCID: https://orcid.org/0000-0003-4073-292X, Mann, James, Reynolds, Gavin, Johnston, Blair ORCID: https://orcid.org/0000-0001-9785-6822 and Markl, Daniel ORCID: https://orcid.org/0000-0003-0411-733X;-
-
Item type: Article ID code: 88672 Dates: DateEvent10 May 2024Published4 April 2024Published Online2 April 2024Accepted1 December 2023SubmittedSubjects: Medicine > Pharmacy and materia medica > Pharmaceutical chemistry Department: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences Depositing user: Pure Administrator Date deposited: 12 Apr 2024 10:36 Last modified: 12 Dec 2024 15:11 URI: https://strathprints.strath.ac.uk/id/eprint/88672